The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by the participant · pityriasis rosea
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events, i.e. serious enough to require withdrawal of the treatment · pityriasis rosea
1 finding from 1 review
The proportion of participants with resolution of itch within 2 weeks, as rated by the participant · pityriasis rosea
Acyclovir probably leads to lower proportion of participants with resolution of itch within 2 weeks,… compared with placebo, vitamins, or no treatment (moderate certainty).
1 finding from 1 review
Reduction in itch score within 2 weeks, as rated by the participant · pityriasis rosea
The review found no eligible studies for this question.
1 finding from 1 review
The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by a medical practitioner · pityriasis rosea
Acyclovir probably leads to higher the proportion of participants with good or excellent rash… compared with placebo, vitamins, or no treatment (moderate certainty).
1 finding from 1 review
Minor adverse events not leading to withdrawal of treatment · pityriasis rosea
Acyclovir showed no clear difference in minor participant‐reported adverse events not requiring withdrawal… compared with placebo, vitamins, or no treatment (moderate certainty).
1 finding from 1 review
The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by the participant · pityriasis rosea
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events, i.e. serious enough to require withdrawal of the treatment · pityriasis rosea
1 finding from 1 review
The proportion of participants with resolution of itch within 2 weeks, as rated by the participant · pityriasis rosea
Acyclovir showed no clear difference in the proportion of participants with resolution of itch within 2… compared with erythromycin (low certainty).
1 finding from 1 review
Reduction in itch score within 2 weeks, as rated by the participant · pityriasis rosea
The review found no eligible studies for this question.
1 finding from 1 review
The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by a medical practitioner · pityriasis rosea
1 finding from 1 review
Minor adverse events not leading to withdrawal of treatment · pityriasis rosea
1 finding from 1 review
Duration of symptoms from onset of treatment · men and women with their first episode of genital herpes
1 finding from 1 review
Adverse events · men and women with their first episode of genital herpes
1 finding from 1 review
Duration of lesions from onset of treatment · men and women with their first episode of genital herpes
1 finding from 1 review
Time to recurrence · men and women with their first episode of genital herpes
1 finding from 1 review
Duration of symptoms from onset of treatment · men and women with their first episode of genital herpes
1 finding from 1 review
Duration of lesions from onset of treatment · men and women with their first episode of genital herpes
1 finding from 1 review
Adverse events ‐ pain with topical application · men and women with their first episode of genital herpes
Topical acyclovir showed no clear difference in adverse events ‐ pain with topical application compared with placebo (low certainty).
1 finding from 1 review
Time to recurrence · men and women with their first episode of genital herpes
1 finding from 1 review